Accéder au contenu
Merck

PAI-1 protein is a key molecular effector in the transition from normal to PTSD-like fear memory.

Molecular psychiatry (2021-01-30)
C Bouarab, V Roullot-Lacarrière, M Vallée, A Le Roux, C Guette, M Mennesson, A Marighetto, A Desmedt, P V Piazza, J M Revest
RÉSUMÉ

Moderate stress increases memory and facilitates adaptation. In contrast, intense stress can induce pathological memories as observed in post-traumatic stress disorders (PTSD). A shift in the balance between the expression of tPA and PAI-1 proteins is responsible for this transition. In conditions of moderate stress, glucocorticoid hormones increase the expression of the tPA protein in the hippocampal brain region which by triggering the Erk1/2MAPK signaling cascade strengthens memory. When stress is particularly intense, very high levels of glucocorticoid hormones then increase the production of PAI-1 protein, which by blocking the activity of tPA induces PTSD-like memories. PAI-1 levels after trauma could be a predictive biomarker of the subsequent appearance of PTSD and pharmacological inhibition of PAI-1 activity a new therapeutic approach to this debilitating condition.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Cocktail d'inhibiteurs de protéases, for use with mammalian cell and tissue extracts, DMSO solution
Sigma-Aldrich
Cocktail d′inhibiteurs de phosphatases 3, DMSO solution
Sigma-Aldrich
Corticosterone: HBC complex, free flowing powder
Sigma-Aldrich
Plasminogen Activator Inhibitor-1, Mutant, Human, Recombinant, The Plasminogen Activator Inhibitor-1, Mutant, Human, Recombinant controls the biological activity of Plasminogen Activator. This small molecule/inhibitor is primarily used for Protease Inhibitors applications.